Free Trial

Weiss Ratings Reaffirms "Sell (E+)" Rating for Quantum-Si (NASDAQ:QSI)

Quantum-Si logo with Computer and Technology background

Key Points

  • Weiss Ratings has reaffirmed a "Sell (E+)" rating for Quantum-Si (NASDAQ: QSI), indicating ongoing concerns about the company's stock performance.
  • Quantum-Si reported a quarterly loss of ($0.16) earnings per share, matching analysts' expectations but falling short of revenue estimates at $0.59 million versus the projected $1.28 million.
  • The average price target for Quantum-Si is currently $3.48, with a mixed rating from analysts: two Buy ratings, one Hold, and one Sell.
  • Five stocks to consider instead of Quantum-Si.

Quantum-Si (NASDAQ:QSI - Get Free Report)'s stock had its "sell (e+)" rating restated by stock analysts at Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.

Separately, Canaccord Genuity Group reiterated a "hold" rating and set a $1.00 price target on shares of Quantum-Si in a research report on Tuesday, September 9th. Two analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $3.48.

Get Our Latest Report on Quantum-Si

Quantum-Si Stock Performance

Shares of QSI stock opened at $1.77 on Wednesday. Quantum-Si has a 12 month low of $0.61 and a 12 month high of $5.77. The firm has a market capitalization of $358.41 million, a PE ratio of -2.60 and a beta of 2.89. The firm has a fifty day simple moving average of $1.31 and a two-hundred day simple moving average of $1.47.

Quantum-Si (NASDAQ:QSI - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported ($0.16) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.16). The company had revenue of $0.59 million for the quarter, compared to the consensus estimate of $1.28 million. Quantum-Si had a negative net margin of 3,120.14% and a negative return on equity of 44.57%. On average, equities analysts predict that Quantum-Si will post -0.65 earnings per share for the current fiscal year.

Insider Transactions at Quantum-Si

In related news, insider Todd C. Bennett sold 18,482 shares of the business's stock in a transaction that occurred on Monday, September 22nd. The stock was sold at an average price of $1.68, for a total transaction of $31,049.76. Following the completion of the transaction, the insider directly owned 700,003 shares in the company, valued at approximately $1,176,005.04. The trade was a 2.57% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders sold 42,841 shares of company stock valued at $71,973 over the last 90 days. Company insiders own 30.04% of the company's stock.

Institutional Trading of Quantum-Si

Several hedge funds have recently modified their holdings of QSI. Millennium Management LLC purchased a new stake in shares of Quantum-Si during the 1st quarter worth approximately $4,721,000. Geode Capital Management LLC increased its position in shares of Quantum-Si by 15.1% during the 2nd quarter. Geode Capital Management LLC now owns 3,447,738 shares of the company's stock valued at $6,759,000 after purchasing an additional 452,850 shares during the last quarter. Bank of America Corp DE increased its position in shares of Quantum-Si by 426.6% during the 2nd quarter. Bank of America Corp DE now owns 465,999 shares of the company's stock valued at $913,000 after purchasing an additional 377,504 shares during the last quarter. Nuveen LLC bought a new position in shares of Quantum-Si during the 1st quarter valued at approximately $383,000. Finally, Ameriprise Financial Inc. bought a new position in shares of Quantum-Si during the 2nd quarter valued at approximately $437,000. 39.90% of the stock is owned by hedge funds and other institutional investors.

About Quantum-Si

(Get Free Report)

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Quantum-Si Right Now?

Before you consider Quantum-Si, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.

While Quantum-Si currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.